Baltic states centralise labelling procedure
This article was originally published in Scrip
Executive Summary
Estonia, Latvia and Lithuania have agreed to centralise their drug labelling approval procedure. To date, they had similar procedures which marketing authorisation holders (MAHs) had to follow in each country separately.